220 related articles for article (PubMed ID: 33453013)
1. Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease.
Johnson SA; Rupp AB; Rupp KL; Reddy S
Intern Emerg Med; 2021 Apr; 16(3):677-686. PubMed ID: 33453013
[TBL] [Abstract][Full Text] [Related]
2. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Rothberg MB; Pekow PS; Lahti M; Brody O; Skiest DJ; Lindenauer PK
JAMA; 2010 May; 303(20):2035-42. PubMed ID: 20501925
[TBL] [Abstract][Full Text] [Related]
6. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
[TBL] [Abstract][Full Text] [Related]
8. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
9. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
11. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.
Huang DT; Yealy DM; Filbin MR; Brown AM; Chang CH; Doi Y; Donnino MW; Fine J; Fine MJ; Fischer MA; Holst JM; Hou PC; Kellum JA; Khan F; Kurz MC; Lotfipour S; LoVecchio F; Peck-Palmer OM; Pike F; Prunty H; Sherwin RL; Southerland L; Terndrup T; Weissfeld LA; Yabes J; Angus DC;
N Engl J Med; 2018 Jul; 379(3):236-249. PubMed ID: 29781385
[TBL] [Abstract][Full Text] [Related]
13. Effects of Hospital Practice Patterns for Antibiotic Administration for Pneumonia on Hospital Lengths of Stay and Costs.
Christensen EW; Spaulding AB; Pomputius WF; Grapentine SP
J Pediatric Infect Dis Soc; 2019 May; 8(2):115-121. PubMed ID: 29438527
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis.
Hey J; Thompson-Leduc P; Kirson NY; Zimmer L; Wilkins D; Rice B; Iankova I; Krause A; Schonfeld SA; DeBrase CR; Bozzette S; Schuetz P
Clin Chem Lab Med; 2018 Jul; 56(8):1200-1209. PubMed ID: 29715176
[TBL] [Abstract][Full Text] [Related]
15. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
[TBL] [Abstract][Full Text] [Related]
17. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy.
Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL
Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
Tokman S; Schuetz P; Bent S
Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic practice patterns with procalcitonin levels in patients with acute lower respiratory tract infection.
Costales-Cantrell JK; Chung J; Nomura JH; Ironside KR; Salama PW; Sim JJ
Am J Manag Care; 2022 Feb; 28(2):e35-e41. PubMed ID: 35139294
[TBL] [Abstract][Full Text] [Related]
20. Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina.
Garay OU; Guiñazú G; Cornistein W; Farina J; Valentini R; Levy Hara G
PLoS One; 2021; 16(4):e0250711. PubMed ID: 33930050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
